Cambridge Investment Research Advisors’s Innovator US Equity Buffer ETF October BOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
38,000
+1,667
+5% +$86.2K ﹤0.01% 1684
2026
Q1
$1.74M Buy
36,333
+987
+3% +$48.7K ﹤0.01% 1701
2025
Q4
$1.75M Buy
35,346
+4,063
+13% +$198K ﹤0.01% 1650
2025
Q3
$1.51M Sell
31,283
-6,553
-17% -$307K ﹤0.01% 1727
2025
Q2
$1.72M Sell
37,836
-5,769
-13% -$247K 0.01% 1542
2025
Q1
$1.83M Sell
43,605
-1,123
-3% -$48.7K 0.01% 1410
2024
Q4
$1.93M Buy
44,728
+3,115
+7% +$134K 0.01% 1380
2024
Q3
$1.77M Sell
41,613
-4,853
-10% -$203K 0.01% 1451
2024
Q2
$1.93M Sell
46,466
-1,303
-3% -$53.1K 0.01% 1300
2024
Q1
$1.93M Sell
47,769
-9,173
-16% -$362K 0.01% 1282
2023
Q4
$2.19M Buy
56,942
+6,749
+13% +$247K 0.01% 1139
2023
Q3
$1.78M Buy
50,193
+1,382
+3% +$50.6K 0.01% 1210
2023
Q2
$1.78M Sell
48,811
-3,164
-6% -$110K 0.01% 1240
2023
Q1
$1.76M Sell
51,975
-3,069
-6% -$101K 0.01% 1203
2022
Q4
$1.75M Buy
55,044
+5,082
+10% +$160K 0.01% 1159
2022
Q3
$1.49M Buy
49,962
+1,918
+4% +$60.7K 0.01% 1217
2022
Q2
$1.46M Sell
48,044
-1,389
-3% -$44.4K 0.01% 1212
2022
Q1
$1.68M Sell
49,433
-54
-0.1% -$1.81K 0.01% 1244
2021
Q4
$1.71M Buy
49,487
+4,602
+10% +$156K 0.01% 1232
2021
Q3
$1.47M Sell
44,885
-367
-0.8% -$11.9K 0.01% 1266
2021
Q2
$1.46M Sell
45,252
-539
-1% -$17.2K 0.01% 1290
2021
Q1
$1.43M Sell
45,791
-459
-1% -$14K 0.01% 1202
2020
Q4
$1.39M Sell
46,250
-1,820
-4% -$52.7K 0.01% 1121
2020
Q3
$1.34M Buy
48,070
+761
+2% +$20.6K 0.01% 1018
2020
Q2
$1.23M Hold
47,309
0.01% 1005
2020
Q1
$1.06M Sell
47,309
-4,051
-8% -$102K 0.01% 941
2019
Q4
$1.35M Buy
51,360
+20,955
+69% +$534K 0.01% 993
2019
Q3
$756K Buy
+30,405
New +$760K 0.01% 1243

Other funds holding BOCT

Cambridge Investment Research Advisors's BOCT Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Innovator US Equity Buffer ETF October (BOCT) stake by 4.6% in Q2 2026, buying an estimated $86.2K and bringing the position to 38,000 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

Cambridge Investment Research Advisors first reported a position in BOCT in Q3 2019 and has held it in 28 quarters since. The position peaked at $2.19M in Q4 2023. 121 funds tracked by Wall St. Rank hold BOCT as of Q2 2026.

  • Cambridge Investment Research Advisors held 38,000 shares of Innovator US Equity Buffer ETF October worth $2.02M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,667 Innovator US Equity Buffer ETF October shares in Q2 2026, an estimated $86.2K.
  • Innovator US Equity Buffer ETF October made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1684 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator US Equity Buffer ETF October in Q3 2019 and has held it in 28 quarters since.
  • Cambridge Investment Research Advisors's Innovator US Equity Buffer ETF October position peaked at $2.19M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF October as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.